Renal actinomycosis with muscular invasion post-nephrostomy tube placement

Perinephric abscesses are a rare complication of nephrostomy tube placement. There are several aerobic bacteria that are common culprits of abscess formation. Here we describe a novel report of a perinephric abscess due to Actinomyces odontolyticus. We describe the presentation of illness, imaging and clinical findings, and the prolonged treatment course needed for this medically complex patient.

•

Actinomyces odontolyticus can cause formation of peri-nephric abscesses.

•

Actinomyces odontolyticus can cause extensive muscular invasion into retroperitoneal space.

•

Actinomyces ability to colonize urogenital epithelium allows for invasion of damaged epithelium into the peri-renal space.

A case of Cryptococcus gattii infection in South Carolina: A possible challenge to known endemicity

In the United States, C. gattii is considered to be endemic to the Pacific Northwest and although uncommon, additional cases have been documented in other regions including the Southeastern United States. While it has been hypothesized in the past that C. gattii may be endemic to the Southeastern United States, there remains a paucity of evidence. Here, we present a patient with no history of HIV/AIDS and no organ transplant and document the course of his disease and presentation. There were no adverse long-term neurological outcomes in this patient and the combination of steroid use, antifungal agents, and cerebrospinal fluid drainage resulted in his discharge from the hospital after 12 days. This patient’s subacute presentation with vague neurological symptoms highlights the importance of understanding the treatment of rare causes of meningitis.

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

OBJECTIVE

Vancomycin-resistant enterococci (VRE) have become a public health concern with implications for patient mortality and costs. Hospital antibiotic usage may impact VRE incidence, but the relationship is poorly understood. Animal investigations suggest that ceftriaxone may be associated with VRE proliferation. We measured antimicrobial usage and VRE bloodstream infection (VRE-BSI) incidence to test our hypothesis that increased ceftriaxone usage would be associated with a higher incidence of VRE-BSI.

DESIGN

Retrospective cohort study.

SETTING

University of Alabama at Birmingham Medical Center, a 900-bed urban tertiary care hospital.

PARTICIPANTS

All patients admitted during the study period contributed data.

METHODS

We conducted a retrospective analysis of antimicrobial usage and VRE-BSI from 2005 to 2008 (43 months). Antimicrobial usage was quantified as days of therapy (DOTs) per 1,000 patient-days. VRE-BSI incidence was calculated as cases per 1,000 patient-days. Negative binomial regression with adjustment for correlation between consecutive observations was used to measure the association between antimicrobial usage and VRE-BSI incidence at the hospital- and care-unit levels.

RESULTS

VRE-BSI incidence increased from 0.06 to 0.17 infections per 1,000 patient-days. Hospital VRE-BSI incidence was associated with prior-month ceftriaxone DOTs (incidence rate ratio, 1.38 per 10 DOTs; P = .005). After controlling for ceftriaxone, prior-month cephalosporin usage (class) was not predictive of VRE-BSI (P = .70). Similarly, prior-month usage of piperacillin-tazobactam, ceftazidime, cefepime, cefazolin, or vancomycin was not predictive of VRE-BSI when considered individually (P≥ .4 for all comparisons). The final model suggests that type of intensive care unit was related to VRE-BSI incidence.

CONCLUSIONS

Ceftriaxone usage in the prior month, but not cephalosporin (class) or vancomycin usage, was related to VRE-BSI incidence. These findings suggest that an antimicrobial stewardship program that limits ceftriaxone may reduce nosocomial VRE-BSI incidence.